117 related articles for article (PubMed ID: 8312315)
1. Lung transplantation without the use of antilymphocyte antibody preparations.
Kriett JM; Smith CM; Hayden AM; Robert R; Parthasarathy R; Kapelanski DP; Jamieson SW
J Heart Lung Transplant; 1993; 12(6 Pt 1):915-22; discussion 922-3. PubMed ID: 8312315
[TBL] [Abstract][Full Text] [Related]
2. Lung transplantation for cystic fibrosis: 6-year follow-up.
Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of combined heart-lung transplantation: the Stanford experience.
Sarris GE; Smith JA; Shumway NE; Stinson EB; Oyer PE; Robbins RC; Billingham ME; Theodore J; Moore KA; Reitz BA
J Heart Lung Transplant; 1994; 13(6):940-9. PubMed ID: 7865527
[TBL] [Abstract][Full Text] [Related]
4. Heart transplantation in patients over 54 years of age with triple-drug therapy immunosuppression.
Fabbri A; Sharples LD; Mullins P; Caine N; Large S; Wallwork J
J Heart Lung Transplant; 1992; 11(5):929-32. PubMed ID: 1420241
[TBL] [Abstract][Full Text] [Related]
5. Triple-drug immunosuppression for heart transplantation in infants and children.
Brown JW; Turrentine MW; Kesler KA; Mahomed Y; Darragh R; Evans K; Thompson L; Caldwell R
J Heart Lung Transplant; 1993; 12(6 Pt 2):S265-74. PubMed ID: 8312346
[TBL] [Abstract][Full Text] [Related]
6. Survival and functional outcome after single and bilateral lung transplantation. Loyola Lung Transplant Team.
Montoya A; Mawulawde K; Houck J; Sullivan H; Lonchyna V; Blakeman B; Hinkamp T; Garrity E; Pifarre R
Surgery; 1994 Oct; 116(4):712-8. PubMed ID: 7940170
[TBL] [Abstract][Full Text] [Related]
7. Single lung transplantation: a temporal look at rejection, infection, and survival.
Frist WH; Loyd JE; Merrill WH; Stewart JR; Dummer JS; Hoff SJ; Walker B; Bender HW
Am Surg; 1994 Feb; 60(2):94-102. PubMed ID: 8304652
[TBL] [Abstract][Full Text] [Related]
8. Incidence of obliterative bronchiolitis after heart-lung transplantation in children.
Whitehead B; Rees P; Sorensen K; Bull C; Higenbottam TW; Wallwork J; Fabre J; Elliott M; de Leval M
J Heart Lung Transplant; 1993; 12(6 Pt 1):903-8. PubMed ID: 8312313
[TBL] [Abstract][Full Text] [Related]
9. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
10. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
[TBL] [Abstract][Full Text] [Related]
11. Reduced incidence of severe infection after heart transplantation with low-intensity immunosuppression.
Reid KR; Menkis AH; Novick RJ; Pflugfelder PW; Kostuk WJ; Reid J; Whitby JL; Powell AM; McKenzie FN
J Heart Lung Transplant; 1991; 10(6):894-900. PubMed ID: 1756154
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
13. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
14. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
15. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of lung transplantation for cystic fibrosis--Danish results.
Bech B; Pressler T; Iversen M; Carlsen J; Milman N; Eliasen K; Perko M; Arendrup H
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1180-6. PubMed ID: 15541981
[TBL] [Abstract][Full Text] [Related]
17. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
[No Abstract] [Full Text] [Related]
18. Reduction of infectious complications following heart transplantation with triple-drug immunotherapy.
Andreone PA; Olivari MT; Elick B; Arentzen CE; Sibley RK; Bolman RM; Simmons RL; Ring WS
J Heart Transplant; 1986; 5(1):13-9. PubMed ID: 3302153
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cardiac rejection in heart and heart-lung transplantation.
Baldwin JC; Oyer PE; Stinson EB; Starnes VA; Billingham ME; Shumway NE
J Heart Transplant; 1987; 6(6):352-6. PubMed ID: 3121819
[TBL] [Abstract][Full Text] [Related]
20. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.
De Maria R; Minoli L; Parolini M; Gavazzeni G; Gentile M; Grossi P; Livi U; Parisi F; Utili R
J Heart Lung Transplant; 1996 Feb; 15(2):124-35. PubMed ID: 8672515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
